Alfred Lim

Company: Etcembly

Job title: Head of Early Pipeline Research

Seminars:

A Novel Generative AI-Designed T-Cell Receptor Bispecific for Cancer Immunotherapy 3:40 pm

Application of the proprietary machine learning platform, EMLyTM , for TCR discovery leading to the generation of a lead PRAME TCR TCR engineering using EMLyTM for rapid affinity enhancement of the parent molecule by more than 5 million-fold Development of a functional TCR bispecific from this lead molecule, and current advancement towards preclinical phaseRead more

day: Conference Day Two